Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence"

被引：0
|
作者：
Yang, Ju Dong [1 ]
Leise, Michael D. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 06期
关键词：
SOFOSBUVIR PLUS RIBAVIRIN; ADVANCED LIVER-DISEASE; LEDIPASVIR; INFECTION;
D O I：
10.1016/j.jhep.2017.08.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1357 / 1357
页数：1
相关论文
共 50 条
  • [41] The Beginning of the End for Interferon Therapy? - Novel Interferon-free Treatment Options for Hepatitis C
    Zimmermann, H. W.
    Tacke, F.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (05): : 450 - 452
  • [42] Interferon Therapy and Prevention of Hepatocellular Carcinoma in Hepatitis C
    Amit G. Singal
    Jorge A. Marrero
    Digestive Diseases and Sciences, 2012, 57 : 832 - 834
  • [43] Interferon Therapy and Prevention of Hepatocellular Carcinoma in Hepatitis C
    Singal, Amit G.
    Marrero, Jorge A.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 832 - 834
  • [44] Interferon-free therapy is effective and safe for hepatitis C recurrence in liver transplant hepatitis C virus/human immunodeficiency virus coinfected recipients: a case-control study
    Londono, M. -C.
    Manzardo, C.
    Del Campo, S.
    Castells, L.
    Aguilera, V.
    Fernandez, J. R.
    Calvo-Pulido, J.
    Penafiel, J.
    Rimola, A.
    Miro, J. M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S189 - S189
  • [45] Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma
    Uenishi, Takahiro
    Nishiguchi, Shuhei
    Tanaka, Shogo
    Yamamoto, Takatsugu
    Takemura, Shigekazu
    Kubo, Shoji
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (05) : 358 - 362
  • [46] Interval between hepatocellular carcinoma treatment and interferon-free direct-acting antiviral agents against hepatitis C is necessary to suppress tumor recurrence
    Iida, Hiroya
    Osaki, Rie
    Fujimoto, Takehide
    Maehira, Hiromitsu
    Mori, Haruki
    Kitamura, Naomi
    Andoh, Akira
    Tani, Masaji
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (01) : 99 - 105
  • [47] Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients
    Cholongitas, Evangelos
    Pipili, Chrysoula
    Papatheodoridis, George
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9526 - 9533
  • [48] Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients
    Evangelos Cholongitas
    Chrysoula Pipili
    George Papatheodoridis
    World Journal of Gastroenterology, 2015, 21 (32) : 9526 - 9533
  • [49] Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
    Ismail, Mohamed Saleh
    Mohamed, Islam
    Polychronopoulou, Efstathia
    Goss, John A.
    Kuo, Yong-Fang
    Kanwal, Fasiha
    Jalal, Prasun K.
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 701 - 711
  • [50] Interferon-free, direct-acting antiviral therapy for chronic hepatitis C
    Gutierrez, J. A.
    Lawitz, E. J.
    Poordad, F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (11) : 861 - 870
12345